|
|
 |
| Vaccine-Related Journal
Articles |
|
| Diseases and Vaccines |
|
Mass Antibiotic Treatment to Stop
an Outbreak of Meningococcal Disease: A Molecular Analysis
Authors: Katz LH, Zelazny A, Scharf S, et al
Source: Clin Microbiol Infect, September 2007; 13(9):943-946 |
|
| Abstract |
Notice to Readers: Revised Recommendations
of the Advisory Committee on Immunization Practices to Vaccinate
All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795 |
|
| HTML | PDF
(entire issue) |
Meningococcal Vaccines: To Eradicate
the Disease, not the Bacterium
Authors: Taha MK, Alonso JM
Source: Hum Vaccin, July-August 2007; 3(4):149-153 |
|
| Abstract |
|
|
Clonal Waves of Neisseria Colonisation
and Disease in the African Meningitis Belt: Eight-Year Longitudinal
Study in Northern Ghana
Authors: Leimkugel J, Hodgson A, Forgor AA, et al
Source: PLoS Med, March 27, 2007; 4(3):e101 |
|
| Abstract |
General Recommendations on Immunization
Source: MMWR, December 1, 2006; 55(RR-15):1-48 |
|
| HTML | PDF
(entire issue) |
Notice to Readers: Recommendation
to resume meningococcal vaccination of children aged 11-12 years
MMWR, November 3, 2006, Vol. 55(43):1177 |
|
| HTML | PDF
(entire issue) |
Prevention of Meningococcal Disease
Author: Gardner P
Source: N Engl J Med, October 5, 2006, Vol. 355: 1466-1473
Click here for free full-text article |
|
| PDF |
|
Multicenter Surveillance of Invasive
Meningococcal Infections in Children
Authors: Kaplan SL, Schutze GE, Leake JA, et al
Source: Pediatrics, October 2006, Vol. 118(4):e979-984 |
|
| Abstract |
Inadvertent Misadministration of Meningococcal
Conjugate Vaccine --- United States, June--August 2005
Source: MMWR, September 22, 2006, Vol. 55(37):1016-1017 |
|
| HTML | PDF
(entire issue) |
Notice to Readers: Limited Supply
of Meningococcal Conjugate Vaccine, Recommendation to Defer Vaccination
of Persons Aged 11--12 Years
Source: MMWR, May 26, 2006 Vol. 55(20):567-568 |
|
| HTML | PDF
(entire issue) |
Update: Guillain-Barré Syndrome Among
Recipients of Menactra® Meningococcal Conjugate Vaccine --- United
States, October 2005--February 2006
Source: MMWR, April 7, 2006, Vol. 55(13):364-366 |
|
| HTML |
Antibody Persistence 3 Years after
Immunization of Adolescents With Quadrivalent Meningococcal Conjugate
Vaccine
Authors: Mitchell P, Dela Cruz JV, Granoff DM et al
Source: J Infect Dis, March 15, 2006, Vol. 193(6):821-882 |
|
| Abstract |
Population-Based Analysis of Meningococcal
Disease Mortality in the United States: 1990-2002
Authors: Sharip A, Sorvillo F, Redelings MD, et al
Source: Pediatr Infect Dis J, March 2006, Vol. 25(3):191-194 |
|
| Abstract |
Prevention of Meningococcal Disease
Author: Kimmel SR
Source: Am Fam Physician, Nov. 15, 2005, Vol. 72(10):2049-2056 |
|
| Abstract |
Guillain-Barré Syndrome Among Recipients
of Menactra® Meningococcal Conjugate Vaccine --- United States,
June--July 2005
Source: MMWR, October 14, 2005, Vol. 54(40):1023-1025 |
|
| HTML |
Prevention and Control of Meningococcal
Disease: Recommendations of the Advisory Committee on Immunization
Practices (ACIP)
Source: MMWR, May 27, 2005, Vol. 54(RR07):1-21 |
|
| PDF |
Prevention and Control of Meningococcal
Disease: Recommendations for Use of Meningococcal Vaccines in Pediatric
Patients
Source: American Academy of Pediatrics, May 25, 2005 |
|
| PDF |
Cost-effectiveness of Conjugate Meningococcal
Vaccination Strategies in the United States
Authors: Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, et al
Source: Pediatrics, May 2005, Vol. 115(5):1220-1232 |
|
| Abstract |
Meningococcal Vaccine: New Product,
New Recommendations
Author: Campos-Outcalt D
Source: J Fam Pract, April 2005, Vol. 54(4):324-326 |
|
| Abstract |
Comparative Trial of the Safety and
Immunogenicity of Quadrivalent (A, C, Y, W-135) Meningococcal Polysaccharide-diphtheria
Conjugate Vaccine Versus Quadrivalent Polysaccharide Vaccine in
Two- to Ten-year-old Children
Authors: Pichichero M, Casey J, Blatter M, et al
Source: Pediatr Infect Dis J, January 2005, Vol. 24(1):57-62 |
|
| Abstract |
Global Epidemiology of Meningococcal
Disease and Vaccine Efficacy
Author: Pollard AJ
Source: Pediatr Infect Dis J, December 2004, Vol. 23(12):S274-S279 |
|
| Abstract |
Meningococcal C Vaccines: The Canadian
Experience
Author: De Wals P
Source: Pediatr Infect Dis J, December 2004, Vol. 23(12):S280-S284 |
|
| Abstract |
Meningococcal Vaccines
Author: Danzig L
Source: Pediatr Infect Dis J, December 2004, Vol. 23(12):S285-S292 |
|
| Abstract |
The Strategy to Control New Zealand's
Epidemic of Group B Meningococcal Disease
Authors: O'Hallahan J, Lennon D, Oster P
Source: Pediatr Infect Dis J, December 2004, Vol. 23(12):S293-S298 |
|
| Abstract |
Cost-effectiveness of Conjugate Meningococcal
Vaccination Strategies in the United States
Authors: Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, et al
Source: Pediatrics, May 2005, Vol. 115(5):1220-1232 |
|
| Abstract |
The Rhode Island Meningitis Vaccine
Experience--Mass Vaccination Campaigns, Politics and Health Policy
Author: Nolan P
Source: Med Health R I, March 2004, Vol. 87(3):65-67 |
|
| Abstract |
Opportunities for Control of Meningococcal
Disease in the United States
Authors: Raghunathan PL, Bernhardt SA, Rosenstein NE
Source: Annu Rev Med, 2004, Vol. 55:333-353 |
|
| Abstract |
Meningococcus
journal articles 2003-1991
|
|
IAC Home